# Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer

> **NCT00336141** · PHASE1 · COMPLETED · sponsor: **University of Southern California** · enrollment: 10 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Suberoylanilide hydroxamic acid

## Key facts

- **NCT ID:** NCT00336141
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00336141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00336141, "Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00336141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*